Mark H. Kirschbaum
Impact in
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Hematology 26
- Acute Myeloid Leukemia Research 15
- Hematopoietic Stem Cell Transplantation 10
-
- Lymphoma Diagnosis and Treatment 18
- Co-authors
- Yosef Yarden (3 shared papers)Gàbor Varadi (2 shared papers)Avraham Amar (2 shared papers)Arnon Nagler (2 shared papers)Shimon Slavin (2 shared papers)Simcha Samuel (2 shared papers)Reuven Or (2 shared papers)Amiram Eldor (1 shared paper)
- Journals
- Blood (36 papers)Clinical Cancer Research (3 papers)Journal of Clinical Oncology (3 papers)British Journal of Haematology (3 papers)Transplantation and Cellular Therapy (2 papers)
- Partner nations
- United StatesAustraliaIsrael
In The Last Decade
Mark H. Kirschbaum
69 papers receiving 5.7k citations
Mark H. Kirschbaum's Hit Papers
Peers
Comparison fields: 5 of 68
- Hematology 1.9k
- Pathology and Forensic Medicine 888
- Dermatology 229
- Oncology 467
- Genetics 148
Countries citing papers authored by Mark H. Kirschbaum
This map shows the geographic impact of Mark H. Kirschbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Kirschbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Kirschbaum more than expected).
Fields of papers citing papers by Mark H. Kirschbaum
This network shows the impact of papers produced by Mark H. Kirschbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Kirschbaum. The network helps show where Mark H. Kirschbaum may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark H. Kirschbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases Hit paper breakdown → | 1998 | 1796 |
| 2 | Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma Hit paper breakdown → | 2009 | 631 |
| 3 | 1999 | 476 | |
| 4 | Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma Hit paper breakdown → | 2011 | 412 |
| 5 | 2015 | 309 | |
| 6 | 2012 | 230 | |
| 7 | 2011 | 179 | |
| 8 | 2005 | 168 | |
| 9 | 2008 | 123 | |
| 10 | 2014 | 115 | |
| 11 | 2013 | 104 | |
| 12 | 2006 | 100 | |
| 13 | 2011 | 95 | |
| 14 | 2008 | 84 | |
| 15 | 2008 | 81 | |
| 16 | 2015 | 67 | |
| 17 | 2005 | 64 | |
| 18 | 2011 | 63 | |
| 19 | 2013 | 61 | |
| 20 | 1998 | 58 |
About Mark H. Kirschbaum
Mark H. Kirschbaum is a scholar working on Hematology, Pathology and Forensic Medicine, Dermatology, Oncology and Genetics, having authored 69 papers that have together received 6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (18 papers), Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (10 papers), Histone Deacetylase Inhibitors Research (5 papers), Cutaneous lymphoproliferative disorders research (5 papers), Cancer-related Molecular Pathways (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Hematology (1.9k citations), Pathology and Forensic Medicine (888 citations), Dermatology (229 citations), Oncology (467 citations) and Genetics (148 citations). Mark H. Kirschbaum has collaborated with scholars based in United States, Australia and Israel. Frequent co-authors include Yosef Yarden, Gàbor Varadi, Avraham Amar, Arnon Nagler, Shimon Slavin, Simcha Samuel, Reuven Or, Amiram Eldor, Ofira Ben‐Tal and Memet Aker. Their work appears in journals such as Blood, Clinical Cancer Research, Journal of Clinical Oncology, British Journal of Haematology and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.